Sulfonylquinolines as central nervous system and cardiovascular agents
US5552411A · kind A · utility
9Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 1995 |
| Grant date | Sep 3, 1996 |
| Priority date | — |
| Expiry date | May 26, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/36
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Sulfonylquinolines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antiobesity agents and for the treatment of hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.